商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1809806
国際登録日2024-06-03
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations and pharmaceuticals; biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.,Pharmaceutical research and development in the field of gene therapy; pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of rna-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.,Medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, tauopathies, synucleinopathies, and neurodegenerative disease.
基礎出願番号90879826
基礎出願日2021-08-12
基礎出願国US
出願人Voyager Therapeutics, Inc.
OCRテキストVOYAGEK
OCRテキスト2VOYAGER
OCRについて

この商標をJ-PlatPatで参照する

関連商標

NUTRITIONAL WHOLESOME BLENDS PTY LTD

Blended. BYSARAH

Renibus Therapeutics, Inc.

Velinor AG c/o Dr. iur. Adrian von Segesser

GAMBRO LUNDIA AB

Solventum Intellectual Properties Company

AETHON THERAPEUTICS, INC.

Renibus Therapeutics, Inc.

TIM Holding B.V.

Guangzhou Healthquest Pharmaceuticals Co., Ltd.

Neolife International, LLC

Xi’an Tianlong Science and Technology Co., Ltd

Zhejiang Lamking Bio-Technology Co.,Ltd

Soletluna Holdings, Inc.

Highridge Medical, LLC

Atara Biotherapeutics, Inc.

F. Hoffmann-La Roche AG

SANOFI BIOTECHNOLOGY

SANOFI BIOTECHNOLOGY

Roche Diagnostics GmbH

Roche Diagnostics GmbH

Azurity Pharmaceuticals, Inc.

PT. INTERNATIONAL LIFE LABORATORIES

Sequitur Health Corp.

DEEP BLUE HEALTH NEW ZEALAND LIMITED

Thommen Medical AG

Thommen Medical AG

続きを見る